Isolated Non-16/18 High-Risk Human Papillomavirus Cervical Infection: Re-Evaluation After One Year

Detalhes bibliográficos
Autor(a) principal: Vargas, Sara
Data de Publicação: 2019
Outros Autores: Valente, Maria Pulido, Almeida, Margarida Mendes de, Neves, Joaquim, Calhaz-Jorge, Carlos
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/10183
Resumo: Introduction: High-risk human papillomavirus cervical infection is currently a well-established cause of cervical cancer. However, only a few women with persistent infections will develop cervical precancerous and malignant lesions. Approximately 20% of all cervical cancers are attributable to non-16/18 serotypes. This study aims to evaluate the results of our clinical approach to women with this infection.Material and Methods: We conducted an observational and prospective study from September 2012 to September 2017, which included women with isolated non-16/18 high-risk human papillomavirus infection (with normal cytology). After re-evaluation, two groups were compared: women with spontaneous regression of the infection and women with persistent infection. Clinical and demographic data were analysed as well as the rate of progression to precancerous and malignant lesions.Results: We included 165 women, of which 121 were re-evaluated with co-test at least one year later. After re-evaluation, 13.2% of women revealed precancerous lesions but only two (1.7%) of them presented high-grade squamous intraepithelial lesions. Sixty-seven women (55.4%) showed spontaneous regression of the infection and 54 women (44.6%) maintained it. Women with persistent infection developed more precancerous lesions (27.8%; p < 0.001) and high-grade squamous intraepithelial lesions (3.7%; p < 0.001). There was also an association between persistent infection and postmenopausal status.Discussion: Human papillomavirus 16/18 cervical infection is associated with higher risk of cervical cancer when compared with other serotypes.Conclusion: Re-evaluation with co-test one year after the diagnosis of isolated non-16/18 human papillomavirus infection seems to be a reasonable approach.
id RCAP_48f68e8c63f9583e5036397dc6976a56
oai_identifier_str oai:ojs.www.actamedicaportuguesa.com:article/10183
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Isolated Non-16/18 High-Risk Human Papillomavirus Cervical Infection: Re-Evaluation After One YearInfeção Cervical Isolada Com HPV de Alto Risco Excluindo os Serotipos 16/18: Reavaliação Após Um AnoGenetic VariationPapillomaviridaePapillomavirus InfectionsPrecancerous ConditionsUterine Cervical NeoplasmsInfecções por PapillomavirusLesões Pré-CancerosasNeoplasias do Colo do ÚteroPapillomaviridaeVariação GenéticaIntroduction: High-risk human papillomavirus cervical infection is currently a well-established cause of cervical cancer. However, only a few women with persistent infections will develop cervical precancerous and malignant lesions. Approximately 20% of all cervical cancers are attributable to non-16/18 serotypes. This study aims to evaluate the results of our clinical approach to women with this infection.Material and Methods: We conducted an observational and prospective study from September 2012 to September 2017, which included women with isolated non-16/18 high-risk human papillomavirus infection (with normal cytology). After re-evaluation, two groups were compared: women with spontaneous regression of the infection and women with persistent infection. Clinical and demographic data were analysed as well as the rate of progression to precancerous and malignant lesions.Results: We included 165 women, of which 121 were re-evaluated with co-test at least one year later. After re-evaluation, 13.2% of women revealed precancerous lesions but only two (1.7%) of them presented high-grade squamous intraepithelial lesions. Sixty-seven women (55.4%) showed spontaneous regression of the infection and 54 women (44.6%) maintained it. Women with persistent infection developed more precancerous lesions (27.8%; p < 0.001) and high-grade squamous intraepithelial lesions (3.7%; p < 0.001). There was also an association between persistent infection and postmenopausal status.Discussion: Human papillomavirus 16/18 cervical infection is associated with higher risk of cervical cancer when compared with other serotypes.Conclusion: Re-evaluation with co-test one year after the diagnosis of isolated non-16/18 human papillomavirus infection seems to be a reasonable approach.Introdução: O cancro cervical é causado pelo papiloma vírus humano de alto risco. No entanto, apenas algumas mulheres com infeções persistentes desenvolvem lesões pré-malignas e malignas. Aproximadamente 20% destas neoplasias são causadas por serotipos que não os 16 e 18. Este estudo surge com o objetivo de avaliar a nossa prática clínica neste âmbito.Material e Métodos: Realizámos um estudo observacional e prospetivo entre setembro de 2012 e setembro de 2017, com inclusão de mulheres com infeção cervical isolada com papiloma vírus humano de alto risco, excluindo os serotipos 16 e 18 (com citologia negativa). Após reavaliação, comparámos dois grupos: mulheres que apresentaram resolução espontânea da infeção e mulheres com infeção persistente. Foram analisados dados clínicos e demográficos bem como a taxa de progressão para lesões precursoras e malignas.Resultados: Incluímos 165 mulheres e reavaliámos com co-teste 121 delas com pelo menos um ano de intervalo. Após reavaliação, 13,2% desenvolveram lesões precursoras, mas apenas duas (1,7%) foram consideradas de alto grau. Sessenta e sete mulheres (55,4%) apresentaram resolução espontânea da infeção e 54 (44,6%) mantiveram-na. As mulheres com infeção persistente desenvolveram mais lesões precursoras (27,8%; p < 0,001) e de alto grau (3,7%; p < 0,001). Constatou-se uma associação entre a persistência da infeção e pós-menopausa.Discussão: A infecção cervical com serotipos 16/18 associa-se a uma maior risco de desenvolvimento de cancro cervical quando comparada com outros serotipos.Conclusão: A reavaliação com co-teste um ano após o diagnóstico de infecção cervical isolada com papiloma vírus humano de alto risco, excluindo os serotipos 16 e 18, parece ser uma abordagem adequada.Ordem dos Médicos2019-09-02info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfapplication/pdfapplication/pdfapplication/mswordapplication/pdfhttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/10183oai:ojs.www.actamedicaportuguesa.com:article/10183Acta Médica Portuguesa; Vol. 32 No. 9 (2019): September; 588-592Acta Médica Portuguesa; Vol. 32 N.º 9 (2019): Setembro; 588-5921646-07580870-399Xreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPenghttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/10183https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/10183/5755https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/10183/9916https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/10183/9917https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/10183/11222https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/10183/11357Direitos de Autor (c) 2019 Acta Médica Portuguesainfo:eu-repo/semantics/openAccessVargas, SaraValente, Maria PulidoAlmeida, Margarida Mendes deNeves, JoaquimCalhaz-Jorge, Carlos2022-12-20T11:05:54Zoai:ojs.www.actamedicaportuguesa.com:article/10183Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T16:19:50.591927Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Isolated Non-16/18 High-Risk Human Papillomavirus Cervical Infection: Re-Evaluation After One Year
Infeção Cervical Isolada Com HPV de Alto Risco Excluindo os Serotipos 16/18: Reavaliação Após Um Ano
title Isolated Non-16/18 High-Risk Human Papillomavirus Cervical Infection: Re-Evaluation After One Year
spellingShingle Isolated Non-16/18 High-Risk Human Papillomavirus Cervical Infection: Re-Evaluation After One Year
Vargas, Sara
Genetic Variation
Papillomaviridae
Papillomavirus Infections
Precancerous Conditions
Uterine Cervical Neoplasms
Infecções por Papillomavirus
Lesões Pré-Cancerosas
Neoplasias do Colo do Útero
Papillomaviridae
Variação Genética
title_short Isolated Non-16/18 High-Risk Human Papillomavirus Cervical Infection: Re-Evaluation After One Year
title_full Isolated Non-16/18 High-Risk Human Papillomavirus Cervical Infection: Re-Evaluation After One Year
title_fullStr Isolated Non-16/18 High-Risk Human Papillomavirus Cervical Infection: Re-Evaluation After One Year
title_full_unstemmed Isolated Non-16/18 High-Risk Human Papillomavirus Cervical Infection: Re-Evaluation After One Year
title_sort Isolated Non-16/18 High-Risk Human Papillomavirus Cervical Infection: Re-Evaluation After One Year
author Vargas, Sara
author_facet Vargas, Sara
Valente, Maria Pulido
Almeida, Margarida Mendes de
Neves, Joaquim
Calhaz-Jorge, Carlos
author_role author
author2 Valente, Maria Pulido
Almeida, Margarida Mendes de
Neves, Joaquim
Calhaz-Jorge, Carlos
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Vargas, Sara
Valente, Maria Pulido
Almeida, Margarida Mendes de
Neves, Joaquim
Calhaz-Jorge, Carlos
dc.subject.por.fl_str_mv Genetic Variation
Papillomaviridae
Papillomavirus Infections
Precancerous Conditions
Uterine Cervical Neoplasms
Infecções por Papillomavirus
Lesões Pré-Cancerosas
Neoplasias do Colo do Útero
Papillomaviridae
Variação Genética
topic Genetic Variation
Papillomaviridae
Papillomavirus Infections
Precancerous Conditions
Uterine Cervical Neoplasms
Infecções por Papillomavirus
Lesões Pré-Cancerosas
Neoplasias do Colo do Útero
Papillomaviridae
Variação Genética
description Introduction: High-risk human papillomavirus cervical infection is currently a well-established cause of cervical cancer. However, only a few women with persistent infections will develop cervical precancerous and malignant lesions. Approximately 20% of all cervical cancers are attributable to non-16/18 serotypes. This study aims to evaluate the results of our clinical approach to women with this infection.Material and Methods: We conducted an observational and prospective study from September 2012 to September 2017, which included women with isolated non-16/18 high-risk human papillomavirus infection (with normal cytology). After re-evaluation, two groups were compared: women with spontaneous regression of the infection and women with persistent infection. Clinical and demographic data were analysed as well as the rate of progression to precancerous and malignant lesions.Results: We included 165 women, of which 121 were re-evaluated with co-test at least one year later. After re-evaluation, 13.2% of women revealed precancerous lesions but only two (1.7%) of them presented high-grade squamous intraepithelial lesions. Sixty-seven women (55.4%) showed spontaneous regression of the infection and 54 women (44.6%) maintained it. Women with persistent infection developed more precancerous lesions (27.8%; p < 0.001) and high-grade squamous intraepithelial lesions (3.7%; p < 0.001). There was also an association between persistent infection and postmenopausal status.Discussion: Human papillomavirus 16/18 cervical infection is associated with higher risk of cervical cancer when compared with other serotypes.Conclusion: Re-evaluation with co-test one year after the diagnosis of isolated non-16/18 human papillomavirus infection seems to be a reasonable approach.
publishDate 2019
dc.date.none.fl_str_mv 2019-09-02
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/10183
oai:ojs.www.actamedicaportuguesa.com:article/10183
url https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/10183
identifier_str_mv oai:ojs.www.actamedicaportuguesa.com:article/10183
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/10183
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/10183/5755
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/10183/9916
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/10183/9917
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/10183/11222
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/10183/11357
dc.rights.driver.fl_str_mv Direitos de Autor (c) 2019 Acta Médica Portuguesa
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Direitos de Autor (c) 2019 Acta Médica Portuguesa
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
application/pdf
application/pdf
application/msword
application/pdf
dc.publisher.none.fl_str_mv Ordem dos Médicos
publisher.none.fl_str_mv Ordem dos Médicos
dc.source.none.fl_str_mv Acta Médica Portuguesa; Vol. 32 No. 9 (2019): September; 588-592
Acta Médica Portuguesa; Vol. 32 N.º 9 (2019): Setembro; 588-592
1646-0758
0870-399X
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799130648338759680